Core Viewpoint - The company has reported significant asset impairment provisions for the first half of 2025, reflecting a cautious approach to its financial reporting and asset management [5][6][7]. Group 1: Company Overview - The company is identified as 起步股份有限公司 (ST Qibu) with the stock code 603557 [1]. - The board of directors and supervisory board members have confirmed the authenticity and completeness of the financial report [1][4]. Group 2: Financial Data - The company has recognized a total asset impairment loss of 41,561,706.09 yuan for the first half of 2025, which includes 22,098,006.19 yuan for inventory and 19,463,699.90 yuan for credit impairment losses [6][7]. - Specific credit impairment losses include 18,916,787.81 yuan for accounts receivable and 546,912.09 yuan for other receivables [6]. Group 3: Asset Impairment Provisions - The board's audit committee has deemed the asset impairment provisions to be reasonable and in accordance with accounting standards [8]. - The supervisory board has also agreed that the provisions align with relevant policies and accurately reflect the company's asset value [9]. Group 4: Fundraising and Usage - The company raised 520 million yuan through convertible bonds, with a net amount of 509.1976 million yuan after expenses [14]. - As of June 30, 2025, the company had four fundraising accounts, with no idle funds being used for cash management during the first half of 2025 [22][27]. Group 5: Project Updates - The "Baby and Children's Products Sales Network Construction Project" has been delayed for over a year, with planned investments of 35,072.09 million yuan, of which 18,957.56 million yuan is expected to be funded from the raised capital [28][29]. - The "Smart Information System Upgrade Project" has also seen slow progress, with only 2,332.60 million yuan of the planned 17 million yuan utilized as of June 30, 2025 [29][30].

Group 1 - Company ST Qibu announced a provision for asset impairment amounting to approximately 41.56 million yuan for the first half of 2025, which will reduce the total profit for that period by the same amount [1] - In the year 2024, the revenue composition of ST Qibu is as follows: 97.91% from the footwear and apparel industry, and 2.09% from other businesses [1]

公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 起步股份有限公司（以下简称"公司"或"起步股份"）于 2025 年 8 月 28 日召开的第四届董事会第四次会议和第四届监事会第四次会议分别审议通过《关 于计提资产减值准备的议案》。现将具体情况公告如下： 证券代码：603557 证券简称：ST 起步 公告编号：2025-063 起步股份有限公司 关于计提资产减值准备的公告 一、本次计提资产减值准备的情况概述 根据《企业会计准则》和公司会计政策的相关规定，为准确、客观地反映公 司 2025 年 6 月 30 日的财务状况及 2025 年度 1-6 月的经营成果，公司对 2025 年度 1-6 月财务报告合并会计报表范围内的应收票据、应收款项、其他应收款、 存货、固定资产等资产进行了清查、分析和评估，对部分可能发生信用及资产减 值的资产计提了相关减值准备。 二、计提资产减值准备的具体情况说明 （一）根据《企业会计准则》和公司相关会计政策，经公司测算，2025 年度 1-6 月共计提了资产减值损失 22,098,006. ...

证券代码：603557 证券简称：ST 起步 公告编号：2025-065 起步股份有限公司 一、募集资金基本情况 (一) 实际募集资金金额和资金到账时间 经中国证券监督管理委员会《关于核准起步股份有限公司公开发行可转换 公司债券的批复》（证监许可〔2020〕301 号）核准，公司获准发行可转换公司 债券为 52,000 万元，每张面值 100 元，共计 520 万张，发行价格为 100 元/张， 期限 6 年，扣除各项发行费用 1,080.24 万元后，公司本次募集资金净额为 50,919.76 万元。上述募集资金到位情况业经天健会计师事务所（特殊普通合 伙）审验，并于 2020 年 4 月 16 日出具了《验证报告》（天健验〔2020〕76 号）。 (二) 募集资金使用和结余情况 截至 2025 年 6 月 30 日，公司公开发行可转换公司债券募集资金使用情况 如下： 第 1 页 共 12 页 单位：人民币元 项目 序号 金额 募集资金净额 A 509,197,584.91 截至期初累计发生 额 项目投入 B1 23,306,048.38 利息收入净额 B2 12,047,956.11 永久性补充流动资金 ...

2、报告期内各品牌 单位：元 币种：人民币 证券代码：603557 证券简称：ST起步 公告编号：2025-064 起步股份有限公司 2025 年第二季度主要经营数据的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 起步股份有限公司（以下简称"公司"）根据《上海证券交易所上市公司自律 监管指引第 3 号行业信息披露：第十号——服装》的相关规定，现将公司 2025 年第二季度主要经营数据（未经审计）公告如下： 二、报告期内主营业务收入情况 1、报告期内主营业务收入分行业 | 品牌类型 | 主营业务收入 | 主营业务成本 | 毛利率 | 主营业务收 入比上年同 | 主营业务成 本比上年同 | 毛利率比上 年同期增减 | | --- | --- | --- | --- | --- | --- | --- | | | | | （%） | | | | | | | | | 期增减(%) | 期增减(%) | （%） | | ABCKIDS | 32,926,721.41 | 16,962,589.90 | 48.48 | -28.2 ...

证券代码：603557 证券简称：ST 起步 公告编号：2025-067 起步股份有限公司 第四届监事会第四次会议决议公告 同意就 2025 年半年度报告及其摘要发表审核意见如下： 1、公司 2025 年半年度报告的编制和审议程序符合法律法规、《公司章程》 及公司各项内部管理制度的规定； 2、公司 2025 年半年度报告的内容和格式符合中国证监会和上海证券交易所 的各项规定，所包含的信息真实反映了公司 2025 年半年度的财务状况和经营业 绩； 3、在发表本意见前，未发现参与 2025 年半年度报告编制和审议的人员有违 反保密规定的行为； 4、监事会同意披露公司 2025 年半年度报告及其摘要。 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、 监事会会议召开情况 起步股份有限公司（以下简称"公司"）第四届监事会第四次会议通知于 2025 年 8 月 21 日以电子邮件方式向全体监事发出，会议于 2025 年 8 月 28 日在浙江 省湖州市吴兴区湖织大道仁祥现代产业园 3 幢会议室以现场结合通讯方式召开。 公司应参加表决 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 起步股份有限公司（以下简称"公司"）第四届董事会第四次会议于 2025 年 8 月 28 日在浙江省湖州市吴兴区湖织大道仁祥现代产业园 3 幢会议室以现场 结合通讯表决的方式召开。 本次会议由董事长陈丽红负责召集，并于 2025 年 8 月 21 日以邮件方式通知 全体董事。公司董事陈丽红、陈钊、胡培诗、陈卫东、许强均出席了会议。本次 会议的召开符合《公司法》等法律、法规及《公司章程》的规定。 本次会议由董事长陈丽红主持，以记名投票表决的方式通过了以下议案： 一、审议通过《关于公司 2025 年半年度报告及其摘要的议案》。 证券代码：603557 证券简称：ST 起步 公告编号：2025-066 起步股份有限公司 第四届董事会第四次会议决议公告 具体内容公司同日于上海证券交易所网站（www.sse.com.cn）披露的《2025 年半年度报告》（及摘要）。 三、审议通过《关于计提资产减值准备的议案》。 具体内容详见公司同日于上海证券交易所网站（www.sse.com.cn）披露的 ...

Market Performance - The apparel and home textile sector increased by 0.67% on August 15, with Dizhu Fashion leading the gains [1] - The Shanghai Composite Index closed at 3696.77, up 0.83%, while the Shenzhen Component Index closed at 11634.67, up 1.6% [1] Top Gainers - Dizhu Fashion (603587) closed at 13.60, up 5.59% with a trading volume of 100,100 shares and a turnover of 133 million yuan [1] - Tianchuang Fashion (603608) closed at 7.21, up 5.56% with a trading volume of 237,600 shares and a turnover of 168 million yuan [1] - ST Qibu (603557) closed at 2.71, up 4.63% with a trading volume of 152,800 shares and a turnover of 40.87 million yuan [1] Top Losers - Langsha Co., Ltd. (600137) closed at 20.04, down 1.86% with a trading volume of 40,400 shares and a turnover of 80.92 million yuan [2] - Russia's Location (002494) closed at 5.07, down 1.74% with a trading volume of 112,100 shares and a turnover of 57.51 million yuan [2] - Ru Yi Zhi Tuan (002193) closed at 6.02, down 1.63% with a trading volume of 102,300 shares and a turnover of 62.31 million yuan [2] Capital Flow - The apparel and home textile sector experienced a net outflow of 92.42 million yuan from institutional investors, while retail investors saw a net inflow of 171 million yuan [2][3] - Major stocks like ST Er Ya (600107) had a net inflow of 21.70 million yuan from institutional investors, but a net outflow from retail investors [3]

Group 1 - The core point of the article indicates that ST Qibu (603557) experienced a decline in stock price, closing at 2.66 yuan, down 2.56% with a turnover rate of 2.73% and a trading volume of 170,200 hands, amounting to 45.29 million yuan [1] - The latest financial performance of ST Qibu shows total operating revenue of 62.35 million yuan for Q1 2025, a year-on-year decrease of 12.54%, while net profit attributable to shareholders was 1.98 million yuan, an increase of 45.69% year-on-year [1] - The company has a current ratio of 1.071, a quick ratio of 0.916, and a debt-to-asset ratio of 78.87% [1] Group 2 - ST Qibu has made investments in 21 companies and participated in 28 bidding projects, indicating active engagement in business expansion [2] - The company holds 325 trademark registrations and 843 patents, showcasing its focus on intellectual property [2] - ST Qibu has obtained 9 administrative licenses, reflecting its compliance and operational capabilities [2]

Market Overview - The Shanghai Composite Index closed at 3653.50 points, with a change of +0.51% [1] - The total trading volume of A-shares reached 1,149.623 billion yuan [1] Technical Analysis - A total of 17 A-shares experienced a "death cross" where the 5-day moving average fell below the 10-day moving average [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - Angli (002940) with a distance of -1.91% - Chengdu Xian Dao (688222) with a distance of -1.51% - Saiseng Pharmaceutical (300485) with a distance of -1.38% [1] Individual Stock Performance - Angli (002940) saw a daily increase of 2.02% with a turnover rate of 4.48% [1] - Chengdu Xian Dao (688222) increased by 1.47% with a turnover rate of 2.10% [1] - Saiseng Pharmaceutical (300485) experienced a slight decrease of -0.14% with a turnover rate of 3.10% [1] - Other stocks with notable performance include: - Jintai (688443) up by 1.78% - Changshan Pharmaceutical (300255) up by 2.29% - Zhizheng (603991) down by -1.69% [1]